Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Recognizing errors to avoid in budgeting can lead to improved financial outcomes. Learn what mistakes to sidestep for success.
12,071 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Costco's strength goes beyond its membership fees. This article reveals how Kirkland Signature quietly grew into Cost...
Small-cap growth ETFs can be a powerful part of a diversified portfolio. This article compares ISCG and SLYG on costs...
Kestra Medical (KMTS) is in focus as Q3 2026 results hit the tape. This article breaks down what the transcript revea...
Binance announced a sweeping delisting of eight altcoins, sending prices lower and forcing traders to reassess holdin...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Many retirees blend leisure with work, but part-time retirement could affect your Social Security in meaningful ways....
A 28-year-old with $730,000 zero debt asks Dave Ramsey for guidance on next steps, sparking a broader look at how you...
U.S. policymakers confront a volatile oil backdrop and rising pump prices, weighing reserves, production, and demand ...
Webull rolled out a March 2026 cash-bonuses program, offering tiered deposit matches and a first-transfer reimburseme...
Curious about SoundHound AI's future? This in-depth guide lays out five-year scenarios, key drivers, and concrete tip...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...